Get the Stockscreener App
12.86
3.79%
0.47
Pre-market:
13.68
0.82
+6.38%
Cargo Therapeutics Inc stock is traded at $12.86, with a volume of 202.20K.
It is up +3.79% in the last 24 hours and down -13.69% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
See More
Previous Close:
$12.39
Open:
$12.55
24h Volume:
202.20K
Relative Volume:
0.89
Market Cap:
$591.92M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-3.5865
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
+15.03%
1M Performance:
-13.69%
6M Performance:
-18.76%
1Y Performance:
-38.11%
1-Day Range:
$12.31
$13.10
1-Week Range:
$10.98
$13.10
52-Week Range:
$10.91
$33.92
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
12.86 | 591.92M | 0 | -147.71M | -127.89M | -3.5857 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
CARGO Therapeutics, Inc. Enters into Sublease Agreement with Vaxcyte, Inc -July 08, 2024 at 04:18 pm EDT - Marketscreener.com
Q1 Earnings Forecast for CRGX Issued By William Blair - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Shares Up 10%What's Next? - MarketBeat
Analysts Issue Forecasts for CRGX Q1 Earnings - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Acquired by Barclays PLC - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Trading Down 3.2%Here's Why - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Hits New 52-Week LowTime to Sell? - MarketBeat
CARGO Therapeutics stock hits 52-week low at $12.17 - Investing.com India
Jane Street Group LLC Decreases Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Sold by Jane Street Group LLC - MarketBeat
CARGO Therapeutics Provides Corporate Update and Anticipated Milestones for 2025 - GlobeNewswire
CARGO Therapeutics Advances CAR T-Cell Pipeline, Unveils Novel Allogeneic Platform With $368M Cash Position - StockTitan
When (CRGX) Moves Investors should Listen - Stock Traders Daily
CARGO Therapeutics (NASDAQ:CRGX) Shares Up 7.4%Still a Buy? - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Shares Down 4.8%Should You Sell? - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Sees Significant Growth in Short Interest - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Trading 5.7% HigherHere's Why - MarketBeat
Barclays PLC Grows Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - MarketBeat
Barclays PLC Purchases 39,102 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Trading Down 6.2%What's Next? - MarketBeat
(CRGX) Trading Advice - Stock Traders Daily
Axsome Therapeutics, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Geode Capital Management LLC Has $15.47 Million Stock Holdings in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Acquired by Geode Capital Management LLC - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Shares Gap DownShould You Sell? - MarketBeat
State Street Corp Acquires 88,000 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Down 3.7%Here's Why - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Trading Up 5.4%Here's Why - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Reaches New 1-Year LowHere's What Happened - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Down 5.1%Here's What Happened - MarketBeat
Down -14.13% in 4 Weeks, Here's Why CARGO Therapeutics, Inc. (CRGX) Looks Ripe for a Turnaround - MSN
CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
CARGO Therapeutics to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan
Corcept Therapeutics’ Cushing’s syndrome therapy shows promise in Phase III trial - Yahoo Finance
GSK’s lung cancer therapy gains EMA PRIME designation - Yahoo Finance
BNP Paribas Financial Markets Boosts Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Australian consumers fret over the economy in December, survey shows - Yahoo Finance
Becton Dickinson to Pay $175 Million to Settle SEC Probe - Yahoo Finance
CARGO Therapeutics (NASDAQ:CRGX) Hits New 1-Year LowHere's Why - MarketBeat
Bears are Losing Control Over CARGO Therapeutics, Inc. (CRGX), Here's Why It's a 'Buy' Now - MSN
CARGO Therapeutics stock hits 52-week low at $13.49 By Investing.com - Investing.com UK
Wellington Management Group LLP Increases Stock Holdings in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - MarketBeat
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Acquired by Charles Schwab Investment Management Inc. - MarketBeat
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):